154 related articles for article (PubMed ID: 36609573)
21. Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups.
Millán-Rodríguez F; Chéchile-Toniolo G; Salvador-Bayarri J; Huguet-Pérez J; Vicente-Rodríguez J
J Urol; 2000 Oct; 164(4):1183-7. PubMed ID: 10992362
[TBL] [Abstract][Full Text] [Related]
22. Survival in patients with metachronous second primary lung cancer.
Ha D; Choi H; Chevalier C; Zell K; Wang XF; Mazzone PJ
Ann Am Thorac Soc; 2015 Jan; 12(1):79-84. PubMed ID: 25494009
[TBL] [Abstract][Full Text] [Related]
23. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
[TBL] [Abstract][Full Text] [Related]
24. Second primary cancers in the Vaud and Neuchâtel Cancer Registries.
Levi F; Randimbison L; Rafael BM; Manuela MC; La Vecchia C
Eur J Cancer Prev; 2015 Mar; 24(2):150-4. PubMed ID: 25397586
[TBL] [Abstract][Full Text] [Related]
25. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
26. Risk factors and survival outcomes of metachronous contralateral upper tract urothelial carcinoma.
Wu K; Liang J; Lu Y
Sci Rep; 2020 Oct; 10(1):16600. PubMed ID: 33024233
[TBL] [Abstract][Full Text] [Related]
27. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
[TBL] [Abstract][Full Text] [Related]
28. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement.
Pagano F; Bassi P; Ferrante GL; Piazza N; Abatangelo G; Pappagallo GL; Garbeglio A
J Urol; 1996 Jan; 155(1):244-7. PubMed ID: 7490845
[TBL] [Abstract][Full Text] [Related]
29. Higher than expected association of clinical prostate and bladder cancers.
Singh A; Kinoshita Y; Rovito PM; Landas S; Silberstein J; Nsouli I; Wang CY; Haas GP
J Urol; 2005 May; 173(5):1526-9. PubMed ID: 15821472
[TBL] [Abstract][Full Text] [Related]
30. Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study.
Pawlish KS; Schottenfeld D; Severson R; Montie JE
Prostate; 1997 Oct; 33(2):75-86. PubMed ID: 9316648
[TBL] [Abstract][Full Text] [Related]
31. Synchronous Penile Squamous Cell Carcinoma, Bladder Urothelial Carcinoma and Prostate Adenocarcinoma Diagnosed in One Procedure.
Deng F; Kong MX; Lai J
Anticancer Res; 2022 Jul; 42(7):3601-3605. PubMed ID: 35790255
[TBL] [Abstract][Full Text] [Related]
32. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
Chan E; Garg K; Stohr BA
Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
[TBL] [Abstract][Full Text] [Related]
33. Incidence of subsequent pancreatic adenocarcinoma in patients with a history of nonpancreatic primary cancers.
Amin S; McBride RB; Kline JK; Mitchel EB; Lucas AL; Neugut AI; Frucht H
Cancer; 2012 Mar; 118(5):1244-51. PubMed ID: 21887676
[TBL] [Abstract][Full Text] [Related]
34. Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy.
Wang P; Luo JD; Wu WF; Wang S; Cai SL; Shen BH; Shi SF; Wei KX; Zhang ZG; Chen ZD
Braz J Med Biol Res; 2007 Jul; 40(7):979-84. PubMed ID: 17653452
[TBL] [Abstract][Full Text] [Related]
35. Preoperative scanning: evaluation for metastatic disease in carcinoma of the breast, lung, colon, bladder, and prostate.
Smalley RV; Malmud LS; Ritchie WG
Semin Oncol; 1980 Dec; 7(4):358-69. PubMed ID: 7008200
[No Abstract] [Full Text] [Related]
36. Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma.
Farr DE; Thomas A; Khan SA; Schroeder MC
Oncologist; 2017 Aug; 22(8):895-900. PubMed ID: 28487463
[TBL] [Abstract][Full Text] [Related]
37. Collision metastasis of bladder and prostate carcinoma to a single pelvic lymph node.
Ergen A; Balbay MD; Irwin M; Torno R
Int Urol Nephrol; 1995; 27(6):743-5. PubMed ID: 8725040
[TBL] [Abstract][Full Text] [Related]
38. Increased risk of breast cancer-specific mortality among cancer survivors who developed breast cancer as a second malignancy.
Wang C; Hu K; Deng L; He W; Fang F; Tamimi RM; Lu D
BMC Cancer; 2021 May; 21(1):491. PubMed ID: 33941118
[TBL] [Abstract][Full Text] [Related]
39. The Impact of a History of Different Other Cancers on the Long-Term Outcomes of Patients with Gallbladder Cancer: A Propensity Score-Adjusted, Population-Based Study.
Wang J; Zhang C; Yan D
Technol Cancer Res Treat; 2023; 22():15330338231183937. PubMed ID: 37394878
[TBL] [Abstract][Full Text] [Related]
40. The impact of previous cancer on overall survival of bladder cancer patients and the establishment of nomogram for overall survival prediction.
Wang Z; Zhou Y; Guan C; Ding Y; Tao S; Huang X; Chen L; Zhang F; Zhang R
Medicine (Baltimore); 2020 Sep; 99(38):e22191. PubMed ID: 32957347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
